Loading...
Market
Will Teva successfully appeal the EU fine by the end of 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from Teva Pharmaceuticals or the European Union's legal records
Story
Teva Fined 462 Million Euros by EU for MS Drug Competition Violations
Oct 31, 2024, 11:06 AM
Teva Pharmaceuticals has been fined nearly €463 million (462 million euros) by the European Union’s antitrust watchdog for anti-competitive practices related to MS Drug competition. The fine was imposed for disparaging a rival and misusing the patent system to maintain its market dominance. The European Commission's decision is part of a broader effort to curb unfair competition practices within the pharmaceutical industry. Teva has announced its intention to appeal the decision.
View original story
Similar markets
No action taken • 33%
Formal charges • 33%
Settlement reached • 33%
Cooperation with FTC • 33%
Litigation against FTC • 33%
No significant action • 33%
Fine reinstated • 25%
Fine reduced • 25%
Fine annulled again • 25%
No appeal • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
